Peila, C.; Spada, E.; Deantoni, S.; Iuliano, E.; Moro, G.E.; Giribaldi, M.; Cavallarin, L.; Cresi, F.; Coscia, A.
The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age. Nutrients 2020, 12, 3807.
https://doi.org/10.3390/nu12123807
AMA Style
Peila C, Spada E, Deantoni S, Iuliano E, Moro GE, Giribaldi M, Cavallarin L, Cresi F, Coscia A.
The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age. Nutrients. 2020; 12(12):3807.
https://doi.org/10.3390/nu12123807
Chicago/Turabian Style
Peila, Chiara, Elena Spada, Sonia Deantoni, Ester Iuliano, Guido E. Moro, Marzia Giribaldi, Laura Cavallarin, Francesco Cresi, and Alessandra Coscia.
2020. "The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age" Nutrients 12, no. 12: 3807.
https://doi.org/10.3390/nu12123807
APA Style
Peila, C., Spada, E., Deantoni, S., Iuliano, E., Moro, G. E., Giribaldi, M., Cavallarin, L., Cresi, F., & Coscia, A.
(2020). The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age. Nutrients, 12(12), 3807.
https://doi.org/10.3390/nu12123807